GlassScriptPhysician profile
Amanda D Haneline
NPI 1437477700
$2,229.70
in general payments reported to CMS, 2019-2025
25 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $102 · 2021: $587 · 2022: $204 · 2023: $475 · 2024: $478 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,222.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $519.62 | 2019-2025 | |
| Intuitive Surgical, INC. | $455.57 | 2021 | |
| Aspira Women'S Health INC | $207.95 | 2021-2024 | Ova1 |
| Exeltis, USA INC. | $167.49 | 2021-2025 | Slynd |
| Biogen, INC. | $125.15 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $98.02 | 2020-2023 | Summit Doppler |
| Astellas Pharma US INC | $90.25 | 2023-2025 | Veozah |
| Channel Medsystems, INC. | $84.07 | 2023 | |
| Organon LLC | $64.23 | 2021-2024 | Nexplanon |
| Ethicon US, LLC | $49.89 | 2024-2025 | Stratafix, Ethicon, Echelon Circular |
| Bayer Healthcare Pharmaceuticals INC. | $49.13 | 2019-2020 | |
| Dexcom, INC. | $45.75 | 2023-2025 | Dexcom G6 Transmitter |
| Biotissue Holdings INC. | $38.12 | 2024 | |
| Pfizer INC. | $31.80 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $29.54 | 2025 | Myfembree |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $28.50 | 2024-2025 | |
| Glaxosmithkline, LLC. | $22.51 | 2019 | |
| Millicent US INC | $20.69 | 2025 | Femlyv |
| Olympus America INC. | $17.13 | 2023 | Olympus |
| Hologic Sales and Service, LLC | $15.78 | 2024 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Mylan Pharmaceuticals INC. | $14.55 | 2022 | |
| Merck Sharp & Dohme LLC | $14.54 | 2020 | |
| Novo Nordisk INC | $13.59 | 2023 | Wegovy |
| Medtronic, INC. | $13.52 | 2023 | Truclear |
| Allergan, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Haneline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.